Trial Details
RECRUITINGBasic Information
| Clinical ID | c1935 |
|---|---|
| Identifier | NCT04224558 |
| Trial Title | Stem Cell Transplantation in Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Mesna|DRUG: Cyclophosphamide|DRUG: Filgrastim|PROCEDURE: Apheresis catheter placement|PROCEDURE: Leukapheresis|DRUG: Fludarabine|DRUG: Methylprednisolone|DRUG: Diphenhydramine|DRUG: Acetaminophen|DRUG: anti-thymocyte globulin (rabbit)|DRUG: lymphocyte immune globulin|BIOLOGICAL: Peripheral Blood Stem Cell Infusion|DRUG: Cytoxan |
Participant Information
| Sponsor | Cedars-Sinai Medical Center |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2019-11-15 |
|---|---|
| Primary Completion Date | 2027-09-30 |
| Completion Date | 2027-09-30 |